← All trials
NCT05730439
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 12, 2023
- Primary completion
- Mar 31, 2024
- Completion date
- Dec 31, 2025
- First posted
- Feb 15, 2023
- Last posted
- Aug 30, 2023
- Enrollment
- 75
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ohio State UniversityLead sponsor
- Ohio State UniversityOverall official - principal investigator
- Ohio State UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.